MedTrace Logo

TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting

NCT03639558 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-06-14

Study results available
· View outcomes & findings →

Summary

This is a randomised controlled trial comparing haloperidol + promethazine versus haloperidol + promethazine + chlorpromazine for agitated patients in the emergency department.

Conditions

  • Psychiatric Emergency
  • Aggression
  • Agitation

Interventions

DRUG

Haloperidol + Promethazine + Chlorpromazine

This is the usual treatment given by this hospital during an aggressive psychiatric episode.

DRUG

Haloperidol + Promethazine

This is the second most used psycho-pharmacological combination used in this hospital during an aggressive psychiatric episode.

Sponsors & Collaborators

  • University of Nottingham

    collaborator OTHER

  • Hopital Psychiatrique De La Croix

    collaborator OTHER_GOV

  • Joseph Dib

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-28
Primary Completion
2019-07-01
Completion
2019-07-07
FDA Drug
Yes

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03639558 on ClinicalTrials.gov